Giuseppe Lopalco Selected Research

Interleukin 1 Receptor Antagonist Protein (Anakinra)

1/2022	Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
1/2021	The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature.
1/2021	Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus.
7/2020	Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis.
1/2020	The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.
1/2020	New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.
1/2020	Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
1/2020	Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes.
4/2019	Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
1/2019	Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Lopalco Research Topics

Disease

20	Uveitis 07/2020 - 01/2015
16	Rheumatoid Arthritis 02/2022 - 10/2014
8	Psoriatic Arthritis 01/2022 - 01/2016
8	Behcet Syndrome (Behcet's Syndrome) 11/2020 - 10/2015
8	Inflammation (Inflammations) 01/2020 - 09/2014
7	Vasculitis (Vasculitides) 01/2022 - 06/2016
7	Adult-Onset Still's Disease 01/2021 - 05/2016
7	Necrosis 07/2020 - 06/2015
6	Pericarditis 01/2022 - 01/2015
6	Fever (Fevers) 01/2021 - 01/2014
4	Infections 03/2022 - 07/2015
4	autosomal dominant familial Periodic fever 01/2021 - 09/2014
4	Ankylosing Spondylitis 09/2019 - 11/2016
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 05/2016
3	Hepatitis B 03/2022 - 07/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 10/2019
3	Arthritis (Polyarthritis) 06/2020 - 01/2016
3	Anterior Uveitis 06/2020 - 11/2016
3	Exanthema (Rash) 01/2020 - 01/2019
3	Axial Spondyloarthritis 01/2020 - 07/2018
3	Acquired Immunodeficiency Syndrome (AIDS) 04/2019 - 01/2015
3	Macular Edema 01/2019 - 01/2017
3	Retinal Vasculitis 10/2018 - 01/2017
2	Polymyositis 10/2022 - 01/2017
2	Rheumatic Diseases (Rheumatism) 01/2022 - 11/2018
2	Serositis 01/2022 - 01/2021
2	Proteinuria 01/2021 - 01/2020
2	Scleritis (Episcleritis) 11/2020 - 01/2020
2	Lymphadenopathy 01/2020 - 01/2015
2	Panuveitis 02/2019 - 01/2019
2	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 09/2016 - 10/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2016 - 01/2015
2	Obesity 05/2016 - 12/2015
2	Gout 05/2016 - 01/2015
1	COVID-19 10/2022
1	Dermatomyositis (Dermatopolymyositis) 10/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022
1	Giant Cell Arteritis (Horton Disease) 01/2022
1	Synovitis 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2020
1	Demyelinating Diseases (Demyelinating Disease) 07/2020
1	Multiple Sclerosis 07/2020
1	Fibromyalgia (Fibrositis) 01/2020
1	Pericardial Effusion 01/2020

Drug/Important Bio-Agent (IBA)

18	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 04/2015
16	Biological ProductsIBA 01/2022 - 01/2016
14	Interleukin-1 (Interleukin 1)IBA 01/2021 - 09/2014
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020 - 01/2014
11	Adalimumab (Humira)FDA Link 02/2022 - 01/2016
10	InterleukinsIBA 01/2022 - 01/2015
10	CytokinesIBA 07/2020 - 01/2014
9	Infliximab (Remicade)FDA Link 07/2020 - 06/2015
9	canakinumab FDA Link 01/2020 - 04/2015
8	Antirheumatic Agents (DMARD)IBA 02/2021 - 01/2016
8	Pharmaceutical PreparationsIBA 01/2020 - 05/2016
7	C-Reactive ProteinIBA 01/2022 - 07/2018
6	SteroidsIBA 01/2022 - 01/2017
6	Etanercept (Enbrel)FDA Link 06/2020 - 09/2014
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 09/2014
5	Rituximab (Mabthera)FDA Link 03/2022 - 07/2015
5	Colchicine FDA LinkGeneric 01/2022 - 01/2018
5	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 01/2018
5	tocilizumab (atlizumab)FDA Link 01/2020 - 05/2016
4	secukinumabIBA 01/2022 - 07/2018
4	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 11/2016
4	InflammasomesIBA 01/2021 - 01/2015
4	Monoclonal AntibodiesIBA 07/2020 - 06/2015
4	Fluorescein (Funduscein)FDA LinkGeneric 07/2017 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2015
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021 - 10/2015
3	AntibodiesIBA 07/2020 - 09/2016
3	baricitinibIBA 01/2020 - 01/2019
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 01/2015
2	BNT162 VaccineIBA 10/2022 - 01/2022
2	Ligases (Synthetase)IBA 10/2022 - 09/2016
2	GlucocorticoidsIBA 01/2022 - 11/2020
2	Biosimilar PharmaceuticalsIBA 09/2021 - 01/2019
2	golimumab FDA Link 01/2021 - 07/2019
2	Prostaglandins AIBA 11/2020 - 01/2020
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2020 - 09/2019
2	Abatacept (Orencia)FDA Link 01/2020 - 05/2016
2	CholesterolIBA 01/2020 - 01/2020
2	Certolizumab Pegol FDA Link 07/2019 - 11/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 07/2017 - 01/2017
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2015
2	Transaminases (Aminotransferases)IBA 01/2017 - 07/2015
2	AutoantibodiesIBA 10/2015 - 01/2014
1	mepolizumabIBA 01/2022
1	VaccinesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	N 30IBA 01/2021
1	Cysteine (L-Cysteine)FDA Link 01/2020

Therapy/Procedure

13	Therapeutics 03/2022 - 04/2015
7	Biological Therapy 11/2020 - 07/2015
2	Duration of Therapy 01/2019 - 06/2018
1	Aftercare (After-Treatment) 01/2020